January 21, 2015
- Multinight “Bedside” Closed-Loop Control for Patients with Type 1 Diabetes.
- Performance and Acceptability of a Combined Device for Insulin Infusion and Glucose Sensing in the Home Setting.
- Diazoxide improves hormonal counterregulatory responses to acute hypoglycemia in long-standing Type 1 Diabetes.
- Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual beta-Cell Function in Recent-Onset Type 1 Diabetes.
